HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yorgin, P. D. Articles by Whitesell, L. Search for Related Content PubMed PubMed Citation Articles by Yorgin, P. D. Articles by Whitesell, L.

Effects of Geldanamycin, a Heat-Shock Protein 90-Binding Agent, on T Cell Function and T Cell Nonreceptor Protein Tyrosine Kinases¹

Peter D. Yorgin^2,*, Steven D. Hartson, Abdul M. Fellah^*, Bradley T. Scroggins, Wenjun Huang, Emmanuel Katsanis^*, Jeff M. Couchman^*, Robert L. Matts and Luke Whitesell^*

^* Department of Pediatrics, Steele Memorial Children’s Research Center, University of Arizona, Tucson, AZ 85724; and Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078

The benzoquinoid ansamycins geldanamycin (GA), herbimycin, and their derivatives are emerging as novel therapeutic agents that act by inhibiting the 90-kDa heat-shock protein hsp90. We report that GA inhibits the proliferation of mitogen-activated T cells. GA is actively toxic to both resting and activated T cells; activated T cells appear to be especially vulnerable. The mechanism by which GA acts is reflected by its effects on an essential hsp90-dependent protein, the T cell-specific nonreceptor tyrosine kinase lck. GA treatment depletes lck levels in cultured T cells by a kinetically slow dose-dependent process. Pulse-chase analyses indicate that GA induces the very rapid degradation of newly synthesized lck molecules. GA also induces a slower degradation of mature lck populations. These results correlate with global losses in protein tyrosine kinase activity and an inability to respond to TCR stimuli, but the activity of mature lck is not immediately compromised. Although the specific proteasome inhibitor lactacystin provides marginal protection against GA-induced lck depletion, proteasome inhibition also induces changes in lck detergent solubility independent of GA application. There is no other evidence for the involvement of the proteosome. Lysosome inhibition provides quantitatively superior protection against degradation. These results indicate that pharmacologic inhibition of hsp90 chaperone function may represent a novel immunosuppressant strategy, and elaborate on the appropriate context in which to interpret losses of lck as a reporter for the pharmacology of GA in whole organisms.

This article has been cited by other articles:

				J. Bae, C. Mitsiades, Y.-T. Tai, R. Bertheau, M. Shammas, R. B. Batchu, C. Li, L. Catley, R. Prabhala, K. C. Anderson, et al. Phenotypic and Functional Effects of Heat Shock Protein 90 Inhibition on Dendritic Cell J. Immunol., June 15, 2007; 178(12): 7730 - 7737. [Abstract] [Full Text] [PDF]

				S. J. H. Arlander, S. J. Felts, J. M. Wagner, B. Stensgard, D. O. Toft, and L. M. Karnitz Chaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones J. Biol. Chem., February 3, 2006; 281(5): 2989 - 2998. [Abstract] [Full Text] [PDF]

				Y. Zhang, J.-S. Wang, L.-L. Chen, Y. Zhang, X.-K. Cheng, F.-Y. Heng, N.-H. Wu, and Y.-F. Shen Repression of hsp90{beta} Gene by p53 in UV Irradiation-induced Apoptosis of Jurkat Cells J. Biol. Chem., October 8, 2004; 279(41): 42545 - 42551. [Abstract] [Full Text] [PDF]

				A. Giannini and M.-J. Bijlmakers Regulation of the Src Family Kinase Lck by Hsp90 and Ubiquitination Mol. Cell. Biol., July 1, 2004; 24(13): 5667 - 5676. [Abstract] [Full Text] [PDF]

				P. Bonvini, H. D. Rosa, N. Vignes, and A. Rosolen Ubiquitination and Proteasomal Degradation of Nucleophosmin-Anaplastic Lymphoma Kinase Induced by 17-Allylamino-Demethoxygeldanamycin: Role of the Co-Chaperone Carboxyl Heat Shock Protein 70-Interacting Protein Cancer Res., May 1, 2004; 64(9): 3256 - 3264. [Abstract] [Full Text] [PDF]

				M. C. Rosenhagen, C. Soti, U. Schmidt, G. M. Wochnik, F. U. Hartl, F. Holsboer, J. C. Young, and T. Rein The Heat Shock Protein 90-Targeting Drug Cisplatin Selectively Inhibits Steroid Receptor Activation Mol. Endocrinol., October 1, 2003; 17(10): 1991 - 2001. [Abstract] [Full Text] [PDF]

				H. Holcombe, I. Mellman, C. A. Janeway Jr., K. Bottomly, and B. N. Dittel The Immunosuppressive Agent 15-Deoxyspergualin Functions by Inhibiting Cell Cycle Progression and Cytokine Production Following Naive T Cell Activation J. Immunol., November 1, 2002; 169(9): 4982 - 4989. [Abstract] [Full Text] [PDF]

				M. Wiesgigl and J. Clos Heat Shock Protein 90 Homeostasis Controls Stage Differentiation in Leishmania donovani Mol. Biol. Cell, November 1, 2001; 12(11): 3307 - 3316. [Abstract] [Full Text] [PDF]

				G. M. Scholz, S. D. Hartson, K. Cartledge, L. Volk, R. L. Matts, and A. R. Dunn The Molecular Chaperone Hsp90 Is Required for Signal Transduction by Wild-Type Hck and Maintenance of Its Constitutively Active Counterpart Cell Growth Differ., August 1, 2001; 12(8): 409 - 417. [Abstract] [Full Text] [PDF]